Literature DB >> 10641895

Clinical aspects of ocular leptospirosis in New Caledonia (South Pacific).

E Mancel1, F Merien, L Pesenti, D Salino, G Angibaud, P Perolat.   

Abstract

PURPOSE: The incidence of leptospirosis is very high in New Caledonia (average annual incidence rate: 180/100 000 of the population). To investigate the role of pathogenic leptospires as an aetiological agent of ocular diseases, we report the results of a 5-year survey in New Caledonia.
METHODS: We reviewed 13 patients (corresponding to 17 investigated pathologic eyes) retrospectively. The selection of patients was based on epidemiological data, initial clinical examination, biological confirmation of leptospirosis according to reference procedures and a specific polymerase chain reaction assay. The anatomic criteria of uveitis and the criteria describing the evolution of the disease were those recommended by the International Uveitis Study Group.
RESULTS: Consequent rates of optic neuritis (65%), posterior uveitis (35%), secluded pupil (24%), interstitial keratitis (18%) and pars planitis (12%) were found. Our rates of recurrence (46%) and of ophthalmic complications (82%) were substantial; some symptoms indicated brain involvement.The final visual damage was severe in 35% of eyes.
CONCLUSIONS: Microagglutination and polymerase chain reaction hybridization are complementary tests for the diagnosis of Leptospira-induced ophthalmic lesions. Before deciding on treatment, one must consider the ability of virulent leptospires to persist in immunologically privileged sites such as aqueous humor, cerebrospinal fluid and eukaryotic cells. Polymerase chain reaction is a useful tool for the diagnosis of Leptospira-induced ocular complications, which are probably misdiagnosed if based only on routine laboratory tests. It enables early diagnosis and early specific treatment that now consists of quinolone and cyclines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10641895     DOI: 10.1046/j.1440-1606.1999.00269.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  6 in total

Review 1.  Leptospirosis.

Authors:  P N Levett
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 2.  Oculo-renal disorders in infectious diseases.

Authors:  Hassane Izzedine; Irina Buhaescu; Bahram Bodaghi; Valerie Martinez; Eric Caumes; Phuc Lehoang; Gilbert Deray
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

Review 3.  Infectious optic neuropathies: a clinical update.

Authors:  Rim Kahloun; Nesrine Abroug; Imen Ksiaa; Anis Mahmoud; Hatem Zeghidi; Sonia Zaouali; Moncef Khairallah
Journal:  Eye Brain       Date:  2015-09-28

Review 4.  Role of Diagnostics in Epidemiology, Management, Surveillance, and Control of Leptospirosis.

Authors:  Jane E Sykes; Krystle L Reagan; Jarlath E Nally; Renee L Galloway; David A Haake
Journal:  Pathogens       Date:  2022-03-24

5.  Bilateral acute keratouveitis in leptospirosis: a new entity.

Authors:  Arvind Gupta; Datta Pandian Gulnar; Renuka Srinivasan; Subashini Kaliaperumal
Journal:  Indian J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 1.848

6.  Overlooked Risk for Chronic Kidney Disease after Leptospiral Infection: A Population-Based Survey and Epidemiological Cohort Evidence.

Authors:  Huang-Yu Yang; Cheng-Chieh Hung; Su-Hsun Liu; Yi-Gen Guo; Yung-Chang Chen; Yi-Ching Ko; Chiung-Tseng Huang; Li-Fang Chou; Ya-Chung Tian; Ming-Yang Chang; Hsiang-Hao Hsu; Ming-Yen Lin; Shang-Jyh Hwang; Chih-Wei Yang
Journal:  PLoS Negl Trop Dis       Date:  2015-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.